Delek US Holdings (NYSE: DK) director sells 5,000 common shares

Rhea-AI Filing Summary

Delek US Holdings director Zohar Shlomo sold 5,000 shares of common stock in an open-market transaction at a price of $41.465 per share.

After this sale, Shlomo directly holds 13,989 shares of Delek US Holdings common stock, according to the latest ownership figures reported.

Insider Trade Summary

Net Seller: 5,000 shares ($207,325)

Net Sell 1 txn

Insider Zohar Shlomo

Role Director

Sold 5,000 shs ($207K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,000	$41.465	$207K

Holdings After Transaction: Common Stock — 13,989 shares (Direct)

Footnotes (1)

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zohar Shlomo

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		S		5,000	D	$41.465	13,989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Delek US Holdings (DK) report for Zohar Shlomo?

Delek US Holdings reported that director Zohar Shlomo executed an open-market sale of 5,000 shares of common stock. The transaction was recorded as a sale and involved non-derivative common shares.

At what price did Zohar Shlomo sell Delek US Holdings (DK) shares?

Zohar Shlomo sold 5,000 Delek US Holdings common shares at a price of $41.465 per share. This reflects the transaction price disclosed for the open-market sale on the reported date.

How many Delek US Holdings (DK) shares does Zohar Shlomo hold after the sale?

Following the transaction, Zohar Shlomo directly holds 13,989 shares of Delek US Holdings common stock. This post-transaction ownership figure comes from the same Form 4 insider filing.

What type of Form 4 transaction did Delek US Holdings (DK) disclose?

The Form 4 discloses a non-derivative open-market sale of common stock by director Zohar Shlomo. The transaction code is “S”, indicating a sale in an open market or private transaction.

Did the Delek US Holdings (DK) Form 4 involve any derivative securities?

No derivative securities are shown in this insider report. The filing lists only a common stock transaction and includes no entries in the derivativeSummary section for options, warrants, or other derivative instruments.